Processa Pharmaceuticals, Inc. Increase (Decrease) in Due to Related Parties
Processa Pharmaceuticals, Inc. (PCSA) reported Increase (Decrease) in Due to Related Parties of -$39 for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedParties · last filed 2024-08-13
- Processa Pharmaceuticals, Inc. increase (decrease) in due to related parties for the quarter ending 2024-06-30 was $22.30K.
- Processa Pharmaceuticals, Inc. increase (decrease) in due to related parties for the quarter ending 2024-03-31 was -$22.33K.
- Processa Pharmaceuticals, Inc. increase (decrease) in due to related parties for the quarter ending 2023-12-31 was -$5.75K, a 11378.43% decline year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in due to related parties for the quarter ending 2023-09-30 was $5.79K.
- Processa Pharmaceuticals, Inc. increase (decrease) in due to related parties for fiscal 2023 was -$12.00.
- Processa Pharmaceuticals, Inc. increase (decrease) in due to related parties for fiscal 2022 was -$1.72K, a 101.99% decline from fiscal 2021.
- Processa Pharmaceuticals, Inc. increase (decrease) in due to related parties for fiscal 2021 was $86.64K.
- Processa Pharmaceuticals, Inc. increase (decrease) in due to related parties for fiscal 2020 was -$85.19K.
| Period end | Increase (Decrease) in Due to Related Parties 3 month | Increase (Decrease) in Due to Related Parties 6 month | Increase (Decrease) in Due to Related Parties 9 month | Increase (Decrease) in Due to Related Parties 12 month |
|---|---|---|---|---|
| 2024-06-30 | $22.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$39.00 10-Q · filed 2024-08-13 | -$5.79K derived: sum of 3 quarters · filed 2024-08-13 | $0.00 derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | -$22.33K 10-Q · filed 2024-05-10 | -$28.09K derived: sum of 2 quarters · filed 2024-05-10 | -$22.30K derived: sum of 3 quarters · filed 2024-05-10 | -$22.30K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-12-31 | -$5.75K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $39.00 derived: sum of 2 quarters · filed 2024-03-29 | $39.00 derived: sum of 3 quarters · filed 2024-08-13 | -$12.00 10-K · filed 2024-03-29 |
| 2023-09-30 | $5.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $5.79K derived: sum of 2 quarters · filed 2024-08-13 | $5.74K 10-Q · filed 2023-11-13 | $5.79K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$51.00 10-Q · filed 2024-08-13 | $0.00 derived: sum of 3 quarters · filed 2024-08-13 | $0.00 derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$51.00 10-Q · filed 2024-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-05-10 | $0.00 derived: sum of 3 quarters · filed 2024-05-10 | $0.00 derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $51.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $51.00 derived: sum of 2 quarters · filed 2024-03-29 | $51.00 derived: sum of 3 quarters · filed 2024-03-29 | -$1.72K 10-K · filed 2024-03-29 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | -$1.77K 10-Q · filed 2023-11-13 | $0.00 derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$1.77K 10-Q · filed 2023-08-10 | $0.00 derived: sum of 3 quarters · filed 2023-08-10 | -$11.74K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$1.77K 10-Q · filed 2023-05-15 | $0.00 derived: sum of 2 quarters · filed 2023-05-15 | -$11.74K derived: sum of 3 quarters · filed 2023-05-15 | -$37.69K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $1.77K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$9.97K derived: sum of 2 quarters · filed 2023-03-30 | -$35.92K derived: sum of 3 quarters · filed 2023-03-30 | $86.64K 10-K · filed 2023-03-30 |
| 2021-09-30 | -$11.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$37.69K derived: sum of 2 quarters · filed 2022-11-08 | $84.87K 10-Q · filed 2022-11-08 | -$103.19K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$25.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $96.61K 10-Q · filed 2022-08-11 | -$91.45K derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | $122.56K 10-Q · filed 2022-05-12 | -$65.50K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$188.06K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$85.19K 10-K · filed 2022-03-30 | ||
| 2020-09-30 | $102.88K 10-Q · filed 2021-11-12 | |||
| 2019-09-30 | $23.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $72.23K derived: sum of 2 quarters · filed 2019-11-14 | $46.65K 10-Q · filed 2019-11-14 | $119.73K derived: sum of 4 quarters · filed 2019-11-14 |
| 2019-06-30 | $48.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $22.92K 10-Q · filed 2019-08-14 | $96.00K derived: sum of 3 quarters · filed 2019-08-14 | $56.73K derived: sum of 4 quarters · filed 2019-11-14 |
| 2019-03-31 | -$25.58K 10-Q · filed 2019-05-14 | $47.50K derived: sum of 2 quarters · filed 2019-05-14 | $8.23K derived: sum of 3 quarters · filed 2019-11-14 | -$20.92K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-12-31 | $73.08K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-08 | $33.81K derived: sum of 2 quarters · filed 2019-11-14 | $4.67K derived: sum of 3 quarters · filed 2019-11-14 | $40.69K 10-K/A · filed 2019-04-08 |
| 2018-09-30 | -$39.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$68.42K derived: sum of 2 quarters · filed 2019-11-14 | -$32.39K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | -$29.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $6.88K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $36.02K 10-Q · filed 2019-05-14 | |||
| 2017-12-31 | -$62.37K 10-K/A · filed 2019-04-08 | |||
| 2016-12-31 | -$69.38K 10-K · filed 2018-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |